- 201. ferredoxin
- [iron containing proteins that transfer electrons, usually at a low potential, to flavoproteins. ( CSP )] (UMLS (CSP) C0015858) =Amino Acid, Peptide, or Protein; Biologically Active Substance =iron sulfur protein;
redoxin =rubredoxin;
adrenal ferredoxin | - 251. FET/PLAC PROB NOS-ANTEPA
- [ ] (UMLS (ICD9CM) C0157137) =Disease or Syndrome
|
- 202. ferret
- [animal of the weasel family (Mustela or Putorius furo), about fourteen inches in length. ( CSP )] (UMLS (CSP) C0015859) =Mammal ;
=Carnivora;
| - 252. FET/PLAC PROB NOS-DELIV
- [ ] (UMLS (ICD9CM) C0157136) =Disease or Syndrome
|
- 203. Ferric Hexacyanoferrate (II)
- [A chelating agent with strong binding affinity for thallium, cesium, and other ions. Ferric hexacyanoferrate is used for the treatment of acute and chronic thallium and cesium poisoning. This agent is not absorbed in the gastrointestinal tract and it chelates thallium or cesium ion in the intestines. The resulting complex is eliminated via the feces. ( NCI )] (UMLS (NCI) C0060267) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical
| - 253. FET/PLAC PROB NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0157135) =Disease or Syndrome
|
- 204. ferriheme
- [porphyrin chelate of iron. ( CSP )] (UMLS (CSP) C0015870) =Organic Chemical; Biologically Active Substance =ferroheme;
| - 254. fetal
- [ ] (UMLS (CSP) C0521457) =Functional Concept
|
- 205. ferriporphyrin
- [ ] (UMLS (CSP) C0599764) =Organic Chemical; Biologically Active Substance
| - 255. Fetal
- [(FEET-us) The developing offspring from 7 to 8 weeks after conception until birth. ( NCI )] (UMLS (NCI) C0015965) =Embryonic Structure =Body Part;
|
- 206. ferritin
- [iron containing protein complex that is formed by a combination of ferric iron with the protein apoferritin; one of the chief forms in which iron is stored in the body. ( CSP )] (UMLS (CSP) C0015879) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Metalloprotein;
iron compound | - 256. FETAL & NEWBORN ASP NOS
- [ ] (UMLS (ICD9CM) C1561791) Fetal and newborn aspiration, unspecified;
=Pathologic Function |
- 207. ferritin labeling
- [ ] (UMLS (CSP) C0596566) =Laboratory Procedure
| - 257. Fetal -Epithelial Differentiation
- (UMLS (NCI) C1333607) =Finding
|
- 208. ferrocene
- [coordination complex of ferrous iron sandwiched between two cyclopentadiene rings; fuel additive, catalyst, UV absorber, and other uses. ( CSP )] (UMLS (CSP) C0060264) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=iron compound;
| - 258. FETAL ABNORM NEC-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157095) =Disease or Syndrome
|
- 209. ferrochelatase
- [A mitochondrial enzyme found in a wide variety of cells and tissues. It is the final enzyme in the 8-enzyme biosynthetic pathway of HEME. Ferrochelatase catalyzes ferrous insertion into protoporphyrin IX to form protoheme or heme. Deficiency in this enzyme results in ERYTHROPOIETIC PROTOPORPHYRIA. ( MSH )] (UMLS (CSP) C0015880) =Amino Acid, Peptide, or Protein; Enzyme =lyase;
| - 259. FETAL ABNORM NEC-DELIVER
- [ ] (UMLS (ICD9CM) C0157094) =Disease or Syndrome
|
- 210. ferrocyanide
- [ ] (UMLS (CSP) C0062612) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical =cyanide;
=nitroferricyanide;
| - 260. FETAL ABNORM NEC-UNSPEC
- [ ] (UMLS (ICD9CM) C0157093) =Disease or Syndrome
|
- 211. ferrofluid
- [ ] (UMLS (CSP) C0598193) =Biomedical or Dental Material
| - 261. FETAL ABNORM NOS-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157099) =Disease or Syndrome
|
- 212. ferroheme
- [iron-porphyrin complex that is the color-furnishing portion of hemoglobin; found free in tissues and as the prosthetic group in many hemeproteins. ( CSP )] (UMLS (CSP) C0018966) =Organic Chemical; Biologically Active Substance ;
=metalloporphyrin;
iron compound =ferriheme;
hemin | - 262. FETAL ABNORM NOS-DELIVER
- [ ] (UMLS (ICD9CM) C0157098) =Disease or Syndrome
|
- 213. FERROUS FUMARATE
- [The fumarate salt form of the mineral iron. Administration of ferrous fumarate results in elevation of serum iron concentration, which is then assimilated into hemoglobin, required for the transport of oxygen, or trapped in the reticuloendothelial cells for storage. This agent is used as a dietary supplement, and to prevent or treat iron deficiency related syndromes. ( NCI )] (UMLS (NCI) C0060276) =Organic Chemical; Pharmacologic Substance ;
=Ferrous Compounds;
[TN401] IRON;
Unclassified Ingredients;
TO BE DELETED INGREDIENT PREPARATIONS =FERROUS FUMARATE 200 MG;
More… | - 263. FETAL ABNORM NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0157097) =Disease or Syndrome
|
- 214. Ferrous Gluconate
- [A form of mineral iron for oral administration, Ferrous Gluconate is absorbed in the stomach and small intestine and combines with apoferritin to form ferritin, which is stored in the liver, spleen, red bone marrow, and intestinal mucosa. Important in transport of oxygen by hemoglobin to the tissues, iron is also found in myoglobin, transferrin, and ferritin, and is as a component of many enzymes such as catalase, peroxidase, and cytochromes. (NCI04) ( NCI )] (UMLS (NCI) C0060277) =Organic Chemical; Pharmacologic Substance ;
=Ferrous Compounds;
[TN401] IRON;
Inactive Ingredient Preparations;
=FERROUS GLUCONATE 325 MG;
FERROUS GLUCONATE 324 MG;
FERROUS GLUCONATE 320 MG;
FERROUS GLUCONATE 80 MG;
FERROUS GLUCONATE 240 MG;
FERROUS GLUCONATE 300 MG;
FERROUS GLUCONATE 40 MG;
FERROUS GLUCONATE 86 MG;
FERROUS GLUCONATE 500 MG;
FERROUS GLUCONATE 25 MG;
FERROUS GLUCONATE 100 MG;
FERROUS GLUCONATE 20 MG;
FERROUS GLUCONATE 25 MG/ML;
FERROUS GLUCONATE 300 MG/5ML;
FERROUS GLUCONATE 31.3 MG;
FERROUS GLUCONATE 38.6 MG;
FERROUS GLUCONATE 50 MG;
FERROUS GLUCONATE 65 MG;
IRON (AS FERROUS GLUCONATE) 30 MG;
IRON (AS FERROUS GLUCONATE) 38.6 MG | - 264. Fetal Adenoma
- [A thyroid gland adenoma composed of microfollicular structures. (NCI05) ( NCI )] (UMLS (NCI) C0334328) =Neoplastic Process
|
- 215. FERROUS SULFATE
- [A sulfate salt of mineral iron formulated for oral administration and used as a dietary supplement, ferrous sulfate is absorbed in the stomach and small intestine and combines with apoferritin to form ferritin, which is stored in the liver, spleen, red bone marrow, and intestinal mucosa. Important in transport of oxygen by hemoglobin to the tissues, iron is also found in myoglobin, transferrin, and ferritin, and is a component of many enzymes such as catalase, peroxidase, and cytochromes. ( NCI )] (UMLS (NCI) C0060282) =Pharmacologic Substance; Inorganic Chemical ;
More… | - 265. Fetal and neonatal hemorrhage
- [ ] (UMLS (ICD9CM) C0473800) =Pathologic Function
|
- 216. FERROUS SULFATE, DRIED
- (UMLS (NCI) C0873006) FERROUS SULFATE,DRIED;
FERROUS SULFATE,DRIED PREPARATION =Pharmacologic Substance; Inorganic Chemical ;
=FERROUS SULFATE;
Inactive Ingredient Preparations =FERROUS SULFATE,DRIED 65 MG | - 266. Fetal and newborn aspiration
- [ ] (UMLS (ICD9CM) C1561805) =Pathologic Function
|
- 217. Fertility Assessment and Management
- (UMLS (NCI) C0280429) =Therapeutic or Preventive Procedure ;
| - 267. fetal blood
- [Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. ( MSH )] (UMLS (CSP) C0015925) =Tissue ;
|
- 218. fertility immunology
- [ ] (UMLS (CSP) C0596567) =Occupation or Discipline =Immunology;
| - 268. Fetal blood loss
- [ ] (UMLS (ICD9CM) C0158951) =Disease or Syndrome ;
|
- 219. fertility promoting drug
- [drugs used to increase fertility or to treat infertility in either males or females. ( CSP )] (UMLS (CSP) C0015896) =Pharmacologic Substance ;
=Drug;
=2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine;
| - 269. FETAL BLOOD SAMPLE/BX
- [ ] (UMLS (ICD9CM) C0177285) =Diagnostic Procedure
|
- 220. Fertility Study
- (UMLS (NCI) C0200069) =Diagnostic Procedure
| - 270. fetal cell culture
- [ ] (UMLS (CSP) C0920515) fetus cell culture =Laboratory Procedure
|
- 221. FERTILITY TESTING
- (UMLS (ICD9CM) C0886496) =Finding
| - 271. FETAL DAMG D/T DRUG-UNSP
- [ ] (UMLS (ICD9CM) C0157085) =Disease or Syndrome
|
- 222. Fertility/Fertilization
- [fusion of a spermatozoan with an ovum resulting in the formation of a zygote. ( CSP )] (UMLS (NCI) C0015914) =Organism Function ;
=fecundity;
=in vitro Fertilization;
artificial fertilization | - 272. Fetal death from asphyxia or anoxia before onset of labor or at unspecified time
- [ ] (UMLS (ICD9CM) C0270131) =Injury or Poisoning
|
- 223. Fertiral
- (UMLS (NCI) C0591507) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 273. fetal diagnosis
- [ ] (UMLS (CSP) C0599190) =Diagnostic Procedure ;
|
- 224. Ferumoxsil
- [A silicon-coated iron oxide, and a superparamagnetic contrast agent used in magnetic resonance imaging (MRI). After oral administration, ferumoxsil moves through and occupies the stomach and intestines. During MRI, ferumoxsil generates T1 relaxation, producing a magnetic field and enhancing T2 relaxation, thereby darkening contrast media-containing structures. This allows visualization of adjacent abdominal tissues. ( NCI )] (UMLS (NCI) C0257928) =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical =oxide;
siloxane;
[TN401] IRON;
[DX900] DIAGNOSTICS, OTHER =ferumoxsil 0.175 MG/ML | - 274. FETAL DISPRO NOS-ANTEPAR
- [ ] (UMLS (ICD9CM) C0156987) =Disease or Syndrome ;
|
- 225. Ferumoxtran-10
- [A synthetic ultrasmall superparamagnetic iron oxide composed of dextran-coated iron oxide nanoparticles (also known as 'ultrasmall particulate iron oxides' or USPIO). Ferumoxtran-10, which accumulates in non-cancerous lymphatic tissue, is used as a molecular resonance imaging (MRI) contrast agent. (NCI04) ( NCI )] (UMLS (NCI) C0386370) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
| - 275. FETAL DISPROP NOS-DELIV
- [ ] (UMLS (ICD9CM) C0156986) =Disease or Syndrome ;
|
- 226. Ferumoxytol
- [A superparamagnetic iron oxide nanoparticle coated with a low molecular weight semi-synthetic carbohydrate, polyglucose sorbitol carboxymethyl ether, with potential anti-anemic and imaging properties. After intravenous administration, ferumoxytol replaces iron stores with fewer side effects compared to the use of oral iron. In addition, this agent generates T1 relaxation, producing a magnetic field and enhancing T2 relaxation, thereby darkening contrast media-containing structures in magnetic resonance imaging (MRI). Due to small particle size, ferumoxytol remains in the intravasculature for a prolonged period and so may be used as a blood pool agent. (NCI05) ( NCI )] (UMLS (NCI) C1453192) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
| - 276. FETAL DISPROP NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0156985) =Disease or Syndrome ;
|
- 227. FES
- [Human Oncogene FPS-FES is a mutated variant of FES Gene (FES/FPS Subfamily), which encodes 822 aa 93-kDa Tyrosine-Protein Kinase FES/FPS, a tyrosine-specific protein kinase involved in normal hematopoiesis and containing an FCH and SH2 domain. The FES chromosomal location is linked to a translocation identified in patients with acute promyelocytic leukemia. A truncated transcript is generated utilizing a start site in a far downstream exon. Oncogene FPS-FES disrupts normal cell function. ( NCI )] (UMLS (NCI) C0812383) FPS;
Fujinami Sarcoma Virus and Feline Sarcoma Virus Transforming Gene;
Oncogene FES;
Oncogene FPS-FES =Gene or Genome ;
| - 277. Fetal distress affecting management of mother
- (UMLS (ICD9CM) C0015931) =Disease or Syndrome ;
|
- 228. FET DAMAG D/T DRUG-DELIV
- [ ] (UMLS (ICD9CM) C0157086) =Disease or Syndrome
| - 278. Fetal distress first noted during labor and delivery, in liveborn infant
- [ ] (UMLS (ICD9CM) C1719625) FETAL DISTRS DUR LAB/DEL =Pathologic Function
|
- 229. FET DAMG D/T DIS-ANTEPAR
- [ ] (UMLS (ICD9CM) C0157083) =Disease or Syndrome
| - 279. FETAL DISTRESS NOS
- [ ] (UMLS (ICD9CM) C0270124) =Disease or Syndrome
|
- 230. FET DAMG D/T DIS-DELIVER
- [ ] (UMLS (ICD9CM) C0157082) =Disease or Syndrome
| - 280. Fetal distress, affecting management of mother, antepartum
- [ ] (UMLS (ICD9CM) C0157114) =Disease or Syndrome
|
- 231. FET DAMG D/T DIS-UNSPEC
- [ ] (UMLS (ICD9CM) C0157081) =Disease or Syndrome
| - 281. Fetal distress, affecting management of mother, delivered
- [ ] (UMLS (ICD9CM) C0157113) =Disease or Syndrome
|
- 232. FET DAMG D/T DRUG-ANTEPA
- [ ] (UMLS (ICD9CM) C0157087) =Disease or Syndrome
| - 282. Fetal distress, affecting management of mother, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0157112) =Disease or Syndrome
|
- 233. FET DAMG D/T VIRUS-ANTEP
- [ ] (UMLS (ICD9CM) C0157079) =Disease or Syndrome
| - 283. FETAL EKG
- [ ] (UMLS (ICD9CM) C0177284) =Diagnostic Procedure
|
- 234. FET DAMG D/T VIRUS-DELIV
- [ ] (UMLS (ICD9CM) C0157078) =Disease or Syndrome
| - 284. Fetal Heart
- [The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time. ( MSH )] (UMLS (NCI) C0015935) =Embryonic Structure ;
|
- 235. FET DAMG D/T VIRUS-UNSP
- [ ] (UMLS (ICD9CM) C0157077) =Disease or Syndrome
| - 285. fetal hemoglobin
- [fetal hemoglobin; major component of hemoglobin in the fetus; it has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. ( CSP )] (UMLS (CSP) C0015936) =Amino Acid, Peptide, or Protein; Biologically Active Substance =hemoglobin;
embryo/fetus protein |
- 236. FET DEATH-ANOXIA DUR LAB
- [ ] (UMLS (ICD9CM) C0158928) =Pathologic Function
| - 286. fetal hypoxia
- [Hypoxia in utero, caused by conditions such as inadequate placental function (often abruptio placentae), preeclamptic toxicity, prolapse of the umbilical cord, or complications from anesthetic administration. ( NCI )] (UMLS (CSP) C0349489) =Disease or Syndrome
|
- 237. FET DISTRESS BEFOR LABOR
- [ ] (UMLS (ICD9CM) C0158929) =Pathologic Function
| - 287. fetal infection
- [ ] (UMLS (CSP) C1397629) =Disease or Syndrome
|
- 238. FET GROWTH RET 2500+G
- [ ] (UMLS (ICD9CM) C0158891) =Disease or Syndrome
| - 288. Fetal Lipomatosis
- [A benign disorder characterized by the presence of multiple lipoblastomas. ( NCI )] (UMLS (NCI) C0334475) =Neoplastic Process
|
- 239. FET GROWTH RET 500-749G
- [ ] (UMLS (ICD9CM) C0158884) =Disease or Syndrome
| - 289. fetal macrosomatia
- [ ] (UMLS (CSP) C0599193) =Congenital Abnormality; Disease or Syndrome
|
- 240. FET GROWTH RET 750-999G
- [ ] (UMLS (ICD9CM) C0158885) =Disease or Syndrome
| - 290. fetal macrosomia
- [A condition of fetal overgrowth leading to a large-for-gestational-age FETUS. It is defined as BIRTH WEIGHT greater than 4,000 grams or above the 90th percentile for population and sex-specific growth curves. It is commonly seen in GESTATIONAL DIABETES; PROLONGED PREGNANCY; and pregnancies complicated by pre-existing diabetes mellitus. ( MSH )] (UMLS (CSP) C0015938) =Disease or Syndrome ;
=embryo/fetus disorder;
Diabetes mellitus, antepartum;
Diabetes in Pregnancy;
|
- 241. FET GROWTH RETARD
- [ ] (UMLS (ICD9CM) C0158883) =Disease or Syndrome
| - 291. FETAL MAL 1000-1249G
- [ ] (UMLS (ICD9CM) C0158876) =Disease or Syndrome
|
- 242. FET GROWTH RETARD WTNOS
- [abnormal fetal physical growth or growth potential at any gestational stage. ( CSP )] (UMLS (ICD9CM) C0015934) =Pathologic Function ;
=embryo/fetus disorder;
Growth Disorders;
developmental disease/disorder;
| - 292. FETAL MAL 1250-1499G
- [ ] (UMLS (ICD9CM) C0158877) =Disease or Syndrome
|
- 243. FET GRWTH RET 1000-1249G
- [ ] (UMLS (ICD9CM) C0158886) =Disease or Syndrome
| - 293. FETAL MAL 1500-1749G
- [ ] (UMLS (ICD9CM) C0158878) =Disease or Syndrome
|
- 244. FET GRWTH RET 1250-1499G
- [ ] (UMLS (ICD9CM) C0158887) =Disease or Syndrome
| - 294. FETAL MAL 750-999G
- [ ] (UMLS (ICD9CM) C0158875) =Disease or Syndrome
|
- 245. FET GRWTH RET 1500-1749G
- [ ] (UMLS (ICD9CM) C0158888) =Disease or Syndrome
| - 295. FETAL MALNUTR 1750-1999G
- [ ] (UMLS (ICD9CM) C0158879) =Disease or Syndrome
|
- 246. FET GRWTH RET 1750-1999G
- [ ] (UMLS (ICD9CM) C0158889) =Disease or Syndrome
| - 296. FETAL MALNUTR 2000-2499G
- [ ] (UMLS (ICD9CM) C0158880) =Disease or Syndrome
|
- 247. FET GRWTH RET 2000-2499G
- [ ] (UMLS (ICD9CM) C0158890) =Disease or Syndrome
| - 297. FETAL MALNUTR 2500+G
- [ ] (UMLS (ICD9CM) C0158881) =Disease or Syndrome
|
- 248. FET/PLAC PROB NEC-ANTEPA
- [ ] (UMLS (ICD9CM) C0157133) =Disease or Syndrome
| - 298. FETAL MALNUTR 500-749G
- [ ] (UMLS (ICD9CM) C0158874) =Disease or Syndrome
|
- 249. FET/PLAC PROB NEC-DELIV
- [ ] (UMLS (ICD9CM) C0157132) =Disease or Syndrome
| - 299. FETAL MALNUTRITION
- [ ] (UMLS (ICD9CM) C0158873) =Disease or Syndrome
|
- 250. FET/PLAC PROB NEC-UNSPEC
- [ ] (UMLS (ICD9CM) C0157131) =Disease or Syndrome
| - 300. Fetal malnutrition without mention of "light-for-dates"
- [ ] (UMLS (ICD9CM) C1510504) =Disease or Syndrome ;
|
home 
Armenian-English 
top